| Literature DB >> 34680856 |
Xin Li1,2, Cheng Zou1,2, Mengxun Li1,2, Chengchi Fang1,2, Kui Li3,4, Zhiguo Liu4, Changchun Li1,2.
Abstract
Parthenogenesis activation (PA), as an important artificial breeding method, can stably preserve the dominant genotype of a species. However, the delayed development of PA embryos is still overly severe and largely leads to pre-implantation failure in pigs. The mechanisms underlying the deficiencies of PA embryos have not been completely understood. For further understanding of the molecular mechanism behind PA embryo failure, we performed transcriptome analysis among pig oocytes (meiosis II, MII) and early embryos at three developmental stages (zygote, morula, and blastocyst) in vitro fertilization (IVF) and PA group. Totally, 11,110 differentially expressed genes (DEGs), 4694 differentially expressed lincRNAs (DELs) were identified, and most DEGs enriched the regulation of apoptotic processes. Through cis- and trans-manner functional prediction, we found that hub lincRNAs were mostly involved in abnormal parthenogenesis embryonic development. In addition, twenty DE imprinted genes showed that some paternally imprinted genes in IVF displayed higher expression than that in PA. Notably, we identified that three DELs of imprinted genes (MEST, PLAGL1, and DIRAS3) were up regulated in IVF, and there was no significant change in PA group. Disordered expression of key genes for embryonic development might play key roles in abnormal parthenogenesis embryonic development. Our study indicates that embryos derived from different production techniques have varied in vitro development to the blastocyst stage, and they also affect the transcription level of corresponding genes, such as imprinted genes. This work will help future research on these genes and molecular-assisted breeding for pig parthenotes.Entities:
Keywords: imprinted genes; in vitro fertilization; lincRNAs; parthenogenesis activation; pig
Mesh:
Year: 2021 PMID: 34680856 PMCID: PMC8535918 DOI: 10.3390/genes12101461
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
In vitro embryo development of IVM (In vitro maturation) oocytes after IVF or PA.
| Embryo Source | Total Embryos (0 h) | Cleaved Embryos (48 h) | Blastocysts (6–7 d) |
|---|---|---|---|
| IVF | 125 | 108 (86.38%) | 33 (30.56% a –26.40% b) |
| 305 | 183 (60.00%) | 49 (26.77% a –16.07% b) | |
| 129 | 86 (66.67%) | 19 (22.09% a –14.73% b) | |
| PA | 55 | 46 (83.64%) | 15 (32.60% a –27.27% b) |
| 47 | 43 (91.49%) | 11 (25.58% a –23.40% b) | |
| 49 | 34 (69.39%) | 13 (38.24% a –26.53% b) |
Cleaved embryo yield percentages are calculated on the basis of the cleaved embryos (a) and on the basis of the initial number of oocytes (b).
In vitro embryo development of IVM oocytes after IVF or PA.
| Sample Name | Raw Reads | Clean Reads | Clean Bases | Error Rate (%) | Q20 (%) | Q30 (%) | GC Content (%) | Uniquely Mapping Rate | Overall Alignment Rate |
|---|---|---|---|---|---|---|---|---|---|
| IVF_Z_1 | 137468078 | 104586902 | 13.01 G | 0.03 | 96.73 | 92.23 | 44.97 | 65.65% | 92.07% |
| IVF_Z_2 | 142771986 | 100439624 | 12.43 G | 0.02 | 97.53 | 94.89 | 44.98 | 74.25% | 91.80% |
| IVF_Z_3 | 135512064 | 102006570 | 12.63 G | 0.02 | 96.36 | 92.48 | 46.97 | 73.66% | 94.41% |
| IVF_M_1 | 156959598 | 98837458 | 12.36 G | 0.04 | 98.78 | 96.27 | 45.57 | 74.38% | 95.23% |
| IVF_M_2 | 169026320 | 105937556 | 13.09 G | 0.03 | 97.59 | 94.78 | 46.02 | 65.17% | 92.75% |
| IVF_M_3 | 156859688 | 100002906 | 12.37 G | 0.03 | 97.7 | 95.13 | 47.08 | 66.95% | 92.47% |
| IVF_B_1 | 150759132 | 99269248 | 12.33 G | 0.02 | 97.74 | 94.3 | 48.21 | 70.28% | 94.86% |
| IVF_B_2 | 181545464 | 115480292 | 14.26 G | 0.02 | 95.78 | 92.17 | 39.67 | 63.31% | 92.36% |
| IVF_B_3 | 146705060 | 100166918 | 12.38 G | 0.02 | 98.09 | 95.89 | 49.42 | 71.38% | 93.21% |
| MII_1 | 139913758 | 104812570 | 13.01 G | 0.03 | 95.55 | 90.93 | 45.49 | 76.37% | 95.77% |
| MII_2 | 165517814 | 112417876 | 14 G | 0.02 | 98.04 | 95.7 | 45.71 | 47.38% | 82.04% |
| MII_3 | 176029002 | 129015192 | 16 G | 0.02 | 97.92 | 95.13 | 45.12 | 69.03% | 93.92% |
| PA_Z_1 | 136106014 | 100661316 | 12.5 G | 0.03 | 95.95 | 91.54 | 46 | 69.40% | 92.33% |
| PA_Z_2 | 150617128 | 109910972 | 13.67 G | 0.02 | 97.88 | 95.13 | 45.91 | 74.20% | 94.61% |
| PA_Z_3 | 146127012 | 99562818 | 12.38 G | 0.02 | 97.69 | 94.81 | 46.23 | 75.18% | 94.60% |
| PA_M_1 | 223196572 | 100931396 | 12.42 G | 0.04 | 97.52 | 94.85 | 44.97 | 65.31% | 91.52% |
| PA_M_2 | 188725788 | 101995272 | 12.54 G | 0.03 | 96.72 | 93.15 | 42.28 | 56.11% | 89.39% |
| PA_M_3 | 181377016 | 110631938 | 13.57 G | 0.03 | 95.48 | 91.64 | 43.6 | 47.55% | 82.89% |
| PA_B_1 | 197029468 | 123993046 | 15.39 G | 0.02 | 98.76 | 97.11 | 47.02 | 76.96% | 95.96% |
| PA_B_2 | 219332164 | 144578468 | 17.82 G | 0.02 | 95.57 | 91.51 | 42.61 | 51.02% | 85.29% |
| PA_B_3 | 182772226 | 138010990 | 17.07 G | 0.02 | 95.79 | 91.62 | 44.59 | 55.11% | 87.73% |
MII: MII (meiosis II) oocyte. IVF_Z: in vitro fertilization zygote stage. IVF_M: in vitro fertilization morula stage. IVF_B: in vitro fertilization early blastocyst stage. PA_Z: parthenogenesis activation zygote stage. PA_M: parthenogenesis activation morula stage. PA_B: parthenogenesis activation early blastocyst stage.
Figure 1Unsupervised clustering of the expression profiles and differentially expressed genes (DEGs) between adjacent stages of pig embryos in vitro fertilization (IVF). (A) Unsupervised hierarchical clustering of the expression profiles; (B) Clusters of DEGs between adjacent stages of pig embryos in vitro fertilization (IVF). Gene average log transformed expression values, top GO terms, and corresponding enrichment p-values were listed.
Figure 2Clusters of DEGs between two adjacent stages of pig parthenogenesis activation (PA) embryos. Gene average log transformed expression values, top GO terms, and corresponding enrichment p-values were listed.
Figure 3Top Go terms of its neighboring protein-coding genes.
Figure 4Module-stage correlation analysis and co-expression network analysis of differentially expressed novel lincRNAs and protein-coding genes. (A) Module-stage correlations and corresponding p values; on the left, different colors represent different modules; on the right, red indicates positive correlation, white indicates no correlation, blue indicates negative correlation; each cell contains the correlation and p value given in parentheses. (B) Co-expression networks of differentially expressed novel lincRNAs and protein-coding genes in six modules; top of each panel: heat maps for expression level of co-expressed genes in six modules. Red, increased expression; green, decreased expression. Middle of each panel: bar plots of the average expression of corresponding module eigengenes. Bottom of each panel: pie charts showing the abundance of lincRNAs and protein-coding genes and top Go terms of the latter within each module.
Figure 5Differential expression analysis of imprinted genes and qRT-PCR validation of RNA-seq. (A) Heat map of DE imprinted genes. (B) qRT-PCR analysis of randomly selected imprinted genes, protein-coding genes, and lincRNAs. Red line represents average expression of RNA-seq; blue line represents average expression of qRT-PCR, and C value is the correlation between RNA-seq and qRT-PCR.